My name is Jiwen Xu, and I am currently a Master’s student in Radiation Oncology at the Department of Radiation Oncology and CyberKnife Center, Tianjin Medical University Cancer Institute & Hospital. Our institution is also affiliated with the National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, the State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, and the Key Laboratory of Cancer Prevention and Therapy in Tianjin, PR China.
My research mainly focuses on radiotherapy dose modeling and radiobiological modeling, particularly tumor control probability (TCP) and normal tissue complication probability (NTCP) modeling in stereotactic radiotherapy. I have published multiple academic papers in this field and have experience in statistical analysis, dose–response modeling, and radiotherapy outcome research.
I am highly interested in advancing precision radiotherapy through quantitative modeling and translational research.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none